Last edition
News about Global Pharma
Thermo Fisher Scientific Plans to Acquire Solventum Purification and Filtration Business
Solventum’s Purification & Filtration business is a provider of purification and filtration technologies used in the production of biologics as well as in medical technologies and industrial applications.
Global Pharma | 26/02/2025 | By Aishwarya | 575
Under the terms of the expanded MOU, WuXi XDC's fully integrated ADC discovery service platform will significantly boost the speed and efficiency of LigaChem's ADC development programs.
Global Pharma | 25/02/2025 | By Manvi | 244
Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs
Akeso Inc.'s partner, Summit Therapeutics, has entered a clinical trial collaboration with Pfizer to evaluate ivonescimab, a PD-1/VEGF bispecific antibody, in combination with Pfizer’s ADCs for multiple solid tumour treatments.
Global Pharma | 25/02/2025 | By Manvi | 334
GSK Completes Acquisition of IDRx
IDRX-42 has demonstrated activity against all clinically relevant primary and secondary KIT mutations, a key medical need in current GIST treatment.
Global Pharma | 25/02/2025 | By Aishwarya | 403
Pfizer Signs Marketing and Supply Deal with Mylan Pharmaceuticals
Under the terms of the agreement, Pfizer will retain ownership of the brands, while Mylan will be responsible for their marketing and sales within India for a period of five years.
Global Pharma | 25/02/2025 | By Aishwarya | 881
Evoke Pharma Welcomes Greg Pyszczymuka to Board of Directors
Pyszczymuka is a proven commercial leader with extensive experience in pharmaceutical sales, market access, and revenue growth. He currently serves as Chief Commercial Officer at Aytu BioPharma.
Global Pharma | 25/02/2025 | By Aishwarya | 150
Kineticos Launches Kinvard Bio to Power Next-Gen Antibiotics
KAMRA I is dedicated to combating antimicrobial resistance (AMR) by investing in, creating, and supporting companies that are developing disruptive solutions to address this critical public health issue.
Global Pharma | 25/02/2025 | By Aishwarya | 237
Co-Diagnostics Pulls 510(k) Application for PCR COVID-19 Test
Co-Diagnostics, Inc. announced that, following a collaborative and informative dialogue with the Food and Drug Administration (FDA), the Company has withdrawn its 510(k) application to the FDA for its Co-Dx™ PCR COVID-19 Test on the PCR Pro™, in favor of submitting an enhanced version of the test for 510(k) clearance.
Global Pharma | 24/02/2025 | By Manvi | 326
Zydus Secures USFDA Approval for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg
Zydus Lifesciences Ltd. has received final USFDA approval to manufacture Ibuprofen and Famotidine tablets (800 mg/26.6 mg) at its Ahmedabad facility.
Global Pharma | 24/02/2025 | By Manvi | 315
Indegene Develops Generative AI Platform Cortex for Life Sciences Sector
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain, making medical writing more effective and efficient, and accelerating Medical-Legal-Regulatory (MLR) reviews.
Global Pharma | 24/02/2025 | By Aishwarya | 830
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy